Welcome to CSNpharm! For Research Use Only!
HIV Integrase
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN12254 | Raltegravir potassium | 871038-72-1 | Raltegravir Potassium is an HIV integrase strand transfer inhibitor which acts as the first of the class of antiviral agents active against the human immunodeficiency virus (HIV). |
| CSN12253 | Raltegravir | 518048-05-0 | Raltegravir is a potent integrase IN inhibitor for WT and S217Q PFV IN with IC50 of 90 nM and 40 nM in cell-free assays respectively It shows greater than 1000-fold selectivity for HIV-1 IN over several related Mg2-dependent enzyme such as HCV polymerase HIV reverse transcriptase HIV RNaseH and human - - -polymerases |
| CSN16815 | MK-2048 | 869901-69-9 | MK-2048 is a potent inhibitor of integrase and INR263K with IC50 of 26 nM and 15 nM respectively |
| CSN18639 | LEDGIN6 | 957890-42-5 | HIV-1 integrase inhibitor in the treatment of human immunodeficiency virus HIV infection |
| CSN22210 | HIV-1 integrase inhibitor 4 | 1638504-66-1 | HIV-1 integrase inhibitor 4 is a HIV-1 integrase strand transfer INST inhibitor with an IC50 of 37 nM |
| CSN22211 | HIV-1 integrase inhibitor 3 | 1638504-56-9 | HIV-1 integrase inhibitor 3 is a HIV-1 integrase strand transfer INST inhibitor with an IC50 of 27 nM |
| CSN12955 | Elvitegravir | 697761-98-1 | Elvitegravir is a quinolinemonocarboxylic-acid HIV-1 integrase strand transfer inhibitor used to treat HIV infection. It is also a cytochrome P450 2C9 inducer. |
| CSN15749 | Dolutegravir sodium | 1051375-19-9 | Dolutegravir sodium is an HIV integrase inhibitor IC50 27 nM with modest activity against raltegravir-resistant signature mutants Y143R Q148K N155H and G140SQ148H |
| CSN13497 | Dolutegravir | 1051375-16-6 | Dolutegravir is an integrase inhibitor (IC50 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140SQ148H. |
| CSN10610 | Chicoric acid | 6537-80-0 | Cichoric Acid is a naturally occuring phenylpropanoid found in a variety of plants used as an HIV Integrase inhibitor |
| CSN16297 | Cabotegravir | 1051375-10-0 | Cabotegravir is a potent HIV integrase inhibitor as an oral lead-in tablet and long-acting injectable for the treatment and prevention of HIV infection. Cabotegravir is an inhibitor of OAT1 (IC50 0.81 M) and OAT3 (IC50 0.41 M). |
| CSN18409 | BMS-707035 | 729607-74-3 | BMS-707035 is a potent specific reversible HIV-I integrase inhibitor with IC50 value of 15 nM |
| CSN16972 | Bms-538203 | 543730-41-2 | BMS-538203 is a highly efficient HIV integrase inhibitor and antiviral agent |
| CSN20343 | Bictegravir | 1611493-60-7 | Bictegravir is a potent, unboosted, once-Daily HIV-1 Integrase Strand Transfer inhibitor (INSTI) (IC50 - 1.6 nM) with improved pharmacokinetics and in vitro resistance profile. |
| CSN17501 | BI 224436 | 1155419-89-8 | BI-224436 is an HIV-1 noncatalytic site integrase inhibitor with EC50 values of less than 15 nM against different HIV-1 laboratory strains |
| CSN17820 | (±)-BI-D | 1416258-16-6 | -BI-D is a potent ALLINI An allosteric IN inhibitor that binds integrase at the LEDGFp75 binding site |
| CSN84076 | Cabotegravir sodium | 1051375-13-3 |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
